In relation to GTDs, the TGF-β signaling pathway plays an important role in the development and progression of gestational trophoblastic diseases, suggesting that members of this family may thus be employed as potential therapeutic targets and as diagnostic biomarkers [8]. Here, TGFB1 is linked to gestational trophoblastic neoplasm.